Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in Zambia.

Ishikawa N, Shimbo T, Miyano S, Sikazwe I, Mwango A, Ghidinelli MN, Syakantu G.

PLoS One. 2014 Mar 6;9(3):e90991. doi: 10.1371/journal.pone.0090991. eCollection 2014.

2.

The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV.

Gopalappa C, Stover J, Shaffer N, Mahy M.

AIDS. 2014 Jan;28 Suppl 1:S5-14. doi: 10.1097/QAD.0000000000000083.

PMID:
24468947
3.

WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.

Ciaranello AL, Perez F, Maruva M, Chu J, Engelsmann B, Keatinge J, Walensky RP, Mushavi A, Mugwagwa R, Dabis F, Freedberg KA; CEPAC-International Investigators.

PLoS One. 2011;6(6):e20224. doi: 10.1371/journal.pone.0020224. Epub 2011 Jun 2.

4.

Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda.

Binagwaho A, Pegurri E, Drobac PC, Mugwaneza P, Stulac SN, Wagner CM, Karema C, Tsague L.

PLoS One. 2013;8(2):e54180. doi: 10.1371/journal.pone.0054180. Epub 2013 Feb 20.

5.

Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe.

Ciaranello AL, Perez F, Engelsmann B, Walensky RP, Mushavi A, Rusibamayila A, Keatinge J, Park JE, Maruva M, Cerda R, Wood R, Dabis F, Freedberg KA.

Clin Infect Dis. 2013 Feb;56(3):430-46. doi: 10.1093/cid/cis858. Epub 2012 Nov 30.

6.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
7.

Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana.

VanDeusen A, Paintsil E, Agyarko-Poku T, Long EF.

BMC Infect Dis. 2015 Mar 18;15:130. doi: 10.1186/s12879-015-0859-2.

8.

Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in Zambia.

Scott CA, Iyer HS, Lembela Bwalya D, Bweupe M, Rosen SB, Scott N, Larson BA.

PLoS One. 2013 Aug 28;8(8):e72444. doi: 10.1371/journal.pone.0072444. eCollection 2013.

9.

Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Mar 1;62(8):148-51.

10.

Uptake of guidelines on prevention of mother-to-child transmission of HIV in rural Tanzania: time for change.

Gamell A, Letang E, Jullu B, Mwaigomole G, Nyamtema A, Hatz C, Battegay M, Tanner M.

Swiss Med Wkly. 2013 Mar 14;143:w13775. doi: 10.4414/smw.2013.13775. Review.

11.

The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV.

O'Brien L, Shaffer N, Sangrujee N, Abimbola TO.

Bull World Health Organ. 2014 Mar 1;92(3):162-70. doi: 10.2471/BLT.13.122523. Epub 2014 Jan 10.

12.

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB.

Lancet. 1999 Sep 4;354(9181):803-9.

PMID:
10485721
13.

Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.

Ngarina M, Tarimo EA, Naburi H, Kilewo C, Mwanyika-Sando M, Chalamilla G, Biberfeld G, Ekstrom AM.

PLoS One. 2014 Jan 22;9(1):e85310. doi: 10.1371/journal.pone.0085310. eCollection 2014.

14.

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

Kesho Bora Study Group, de Vincenzi I.

Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Erratum in: Lancet Infect Dis. 2011 Mar;11(3):159. Read, Jennifer S [corrected to Read, Jennifer].

PMID:
21237718
15.

Outcomes in a cohort of women who discontinued maternal triple-antiretroviral regimens initially used to prevent mother-to-child transmission during pregnancy and breastfeeding--Kenya, 2003-2009.

Minniear TD, Girde S, Angira F, Mills LA, Zeh C, Peters PJ, Masaba R, Lando R, Thomas TK, Taylor AW; Kisumu Breastfeeding Study Team.

PLoS One. 2014 Apr 14;9(4):e93556. doi: 10.1371/journal.pone.0093556. eCollection 2014.

16.

Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.

Sweat MD, O'Reilly KR, Schmid GP, Denison J, de Zoysa I.

AIDS. 2004 Aug 20;18(12):1661-71.

PMID:
15280777
17.

Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.

Ngemu EK, Khayeka-Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E.

BMC Res Notes. 2014 Jan 21;7:52. doi: 10.1186/1756-0500-7-52. Retraction in: BMC Res Notes. 2014;7:868.

18.

Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines.

Nelson LJ, Beusenberg M, Habiyambere V, Shaffer N, Vitoria MA, Montero RG, Easterbrook PJ, Doherty MC.

AIDS. 2014 Mar;28 Suppl 2:S217-24. doi: 10.1097/QAD.0000000000000239.

PMID:
24849481
19.

Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers.

Mandala J, Torpey K, Kasonde P, Kabaso M, Dirks R, Suzuki C, Thompson C, Sangiwa G, Mukadi YD.

BMC Public Health. 2009 Aug 27;9:314. doi: 10.1186/1471-2458-9-314.

20.

Cost-effectiveness of a package of interventions for expedited antiretroviral therapy initiation during pregnancy in Cape Town, South Africa.

Zulliger R, Black S, Holtgrave DR, Ciaranello AL, Bekker LG, Myer L.

AIDS Behav. 2014 Apr;18(4):697-705.

Items per page

Supplemental Content

Write to the Help Desk